AKT1 and leukemia: The PI3K/AKT signaling pathway plays a central role in the entirety of leukemia pathogenesis, including cell proliferation, transformation, and extramedullary infiltration, making it a crucial therapeutic target (Lim et al., 2022; Cardoso et al., 2023).